Latest Exploration News

Aston Minerals Limited (ASO) and Torque Metals Limited (TOR) have agreed to merge via court-approved schemes, combining gold resources across Australia and Canada. The merger, recommended by ASO’s board and supported by an independent expert, awaits shareholder and court approval.

De Grey Mining Ltd proposes a scheme of arrangement for acquisition by Northern Star Resources Ltd, offering a 37.1% premium and resulting in a 20% stake for De Grey shareholders in the merged group. The scheme booklet, including an Independent Expert's Report by KPMG, concludes the scheme is fair and reasonable and in the best interests of De Grey shareholders, subject to no superior proposal.

Minerals 260 Limited has launched a $200-$220 million public offer to fund the acquisition of the Bullabulling Gold Project in Western Australia, featuring a 2.3 million ounce JORC-compliant resource. The company seeks ASX re-admission following a significant change in scale of activities.

Iluka Resources has released its inaugural Mineral Resource estimate for the Goschen South deposit in Victoria, revealing a substantial 630 million tonnes grading 3.7% heavy minerals. This discovery positions Iluka to significantly enhance feedstock supply for its pioneering rare earth refinery at Eneabba.

Mineral Resources Limited reported a challenging FY25 half-year with a 9% revenue decline and a 55% drop in underlying EBITDA, yet its Mining Services segment and Onslow Iron project show promising growth trajectories.

Mineral Resources Limited reported a challenging first half of 2025 with significant profit declines amid weaker commodity prices, yet delivered record earnings in Mining Services and advanced its transformative Onslow Iron project.

Mineral Resources Limited posted a substantial $809 million loss for the half-year ending December 2024, driven by lower revenues and significant impairment charges, notably at its Bald Hill lithium project. The company also announced no interim dividend as it focuses on liquidity and operational transitions.

Nyrada Inc. posted a significant $2.46 million loss for H1 FY25, driven by increased R&D spend, while advancing its lead drug NYR-BI03 into first-in-human trials following regulatory approval.

Zelira Therapeutics has received a $1.15 million cash refund from the Australian Government’s R&D Tax Incentive Scheme, bolstering its working capital to advance clinical development and business operations.

Ausmon Resources has completed critical field reconnaissance across three South Australian tenements, setting the stage for a targeted rare earth elements drilling program pending regulatory approval.

Bell Financial Group reported a robust 26.4% increase in profit after tax to $30.7 million for 2024, underpinned by strong performances across all divisions and a declared fully franked final dividend of 4.0 cents per share. The Group is actively pursuing growth through acquisitions and strategic account transfers, positioning itself for a cautiously optimistic 2025.

Ausmon Resources Limited has launched a Share Purchase Plan offering shareholders shares at an 8.6% discount, with potential tax credits for Australian investors. The move aims to strengthen the company’s balance sheet and fund exploration activities.